Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Milica RasicInstitute of Human Genetics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-3269-7872
Nela MaksimovicInstitute of Human Genetics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-5815-573X
Milka GrkInstitute of Human Genetics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-7534-9608
Marija Dusanovic PjevicInstitute of Human Genetics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-3564-2623
Petar RasicDepartment of Abdominal Surgery, Mother and Child Health Care Institute of Serbia "Dr. Vukan Cupic", 11000 Belgrade, Serbia.ORCID 0000-0003-3696-4381
Milos SvircevDepartment of Internal Medicine, General Hospital Pancevo, 23000 Pancevo, Serbia.
Tatjana DamnjanovicInstitute of Human Genetics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Dijana PerovicInstitute of Human Genetics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-1077-2373
Ana Djuranovic UkleinInstitute of Human Genetics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-8144-4433
Natasa StojanovskiInstitute of Human Genetics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Milica PesicInstitute of Human Genetics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Ivana NovakovicInstitute of Human Genetics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Krstina Doklestic VasiljevFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Funding
Ministry of Science, Technological Development, and Innovation of the Republic of Serbia 451-03-66/2024-03/200110
6 · The paper itself
Abstract
Secondary peritonitis (SP) remains a major clinical challenge due to its high complication rates and it often results in sepsis and multi-organ dysfunction. This study investigated the association between four nitric oxide synthase (NOS) single-nucleotide polymorphisms (SNPs)-
Indexed as
Genetic Predisposition to DiseaseNitric Oxide Synthase Type IINitric Oxide Synthase Type IIIPeritonitisPolymorphism, Single NucleotideSepsisAdultAgedFemaleGenotypeHaplotypesHumansMaleMiddle AgedMultiple Organ FailureRespiratory Distress SyndromeNitric Oxide Synthase Type IINitric Oxide Synthase Type IIINOS2 protein, humanNOS3 protein, humanARDShaplotypesMODSMOFNOS2NOS3NOS polymorphismssecondary peritonitissepsis
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.